Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27829696
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 278.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 278.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27829696
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Dis+Markers
2016 ; 2016
(ä): 6248264
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced
Glycation End Products, and Metabolic Syndrome: The Metformin Effect
#MMPMID27829696
Haddad M
; Knani I
; Bouzidi H
; Berriche O
; Hammami M
; Kerkeni M
Dis Markers
2016[]; 2016
(ä): 6248264
PMID27829696
show ga
Metabolic syndrome (MetS) is considered one of the most important public health
problems. Several and controversial studies showed that the role of advanced
glycation end products (AGEs) and their receptor in the development of metabolic
syndrome and therapeutic pathways is still unsolved. We have investigated whether
plasma pentosidine, carboxymethyl-lysine (CML), and soluble receptor for advanced
glycation end products (sRAGE) levels were increased in patients with MetS and
the effect of metformin in plasma levels of pentosidine, CML, and sRAGE. 80
control subjects and 86 patients were included in this study. Pentosidine, CML,
and sRAGE were measured in plasma by enzyme-linked immunosorbent assay (ELISA).
Plasma pentosidine, CML, and sRAGE levels were significantly increased in
patients compared to control subjects (P < 0.001, P < 0.001, and P = 0.014,
resp.). Plasma levels of pentosidine were significantly decreased in patients who
received metformin compared to untreated patients (P = 0.01). However, there was
no significant difference between patients treated with metformin and untreated
patients in plasma CML levels. Plasma levels of sRAGE were significantly
increased in patients who received metformin and ACE inhibitors (P < 0.001 and P
= 0.002, resp.). However, in a multiple stepwise regression analysis,
pentosidine, sRAGE, and drugs treatments were not independently associated.
Patients with metabolic syndrome showed increased levels of AGEs such as
pentosidine and CML. Metformin treatment showed a decreased level of pentosidine
but not of CML. Therapeutic pathways of AGEs development should be taken into
account and further experimental and in vitro studies merit for advanced
research.
|Adult
[MESH]
|Arginine/*analogs & derivatives/blood
[MESH]
|Biomarkers
[MESH]
|Case-Control Studies
[MESH]
|Diabetes Mellitus, Type 2/drug therapy/pathology
[MESH]